Loading organizations...
Vatera Healthcare Partners is a venture capital and private equity firm dedicated to the healthcare sector. It provides investment services, focusing on biopharmaceutical companies and products across diverse development stages and capital structures. They offer financial assistance, analysis, and consulting, aiming to cultivate innovation within their portfolio.
Founded in 2007 by Michael Jaharis, Kevin Thomas Ferro, and Sundar Kodiyalam, Vatera Healthcare Partners emerged from deep industry expertise. Michael Jaharis, founder of Kos Pharmaceuticals and co-founder of Arisaph Pharmaceuticals, brought significant entrepreneurial experience. Sundar Kodiyalam also co-founded the firm, initially as a family office venture capital entity.
The firm primarily supports biopharmaceutical companies requiring capital and strategic guidance. Vatera Healthcare Partners' vision is to advance novel healthcare solutions by investing in companies poised to improve patient care. Their objective is to drive innovation and contribute to the biopharmaceutical industry's evolution.
Key people at Vatera Healthcare Partners.
Vatera Healthcare Partners was founded in 2007 by Kevin Thomas Ferro (Founder, Chief Executive Officer) and Michael Jaharis (Founder) and Sundar Kodiyalam (Founder & Managing Director).
Vatera Healthcare Partners was founded in 2007 by Kevin Thomas Ferro (Founder, Chief Executive Officer) and Michael Jaharis (Founder) and Sundar Kodiyalam (Founder & Managing Director).
Key people at Vatera Healthcare Partners.
Vatera Healthcare Partners has 2 tracked investments across 2 companies. The latest tracked deal is $350K Seed in Amy Wines in January 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 6, 2026 | Amy Wines | $350K Seed | — | Shane Davey, Hmgm Investment Holdings |
| Dec 14, 2011 | ImmusanT | $20.0M Series A | Vatera Healthcare Partners | — |
